Docetaxel - Taxotere

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

88 API Suppliers, 40 USDMF, 28 CEP/COS, 10 JDMF, 8 EU WC, 13 KDMF, 14 NDC API, 42 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

88 Drugs in Development

88 Drugs in Development

INTERMEDIATES

14 Intermediate Suppliers

14 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

296 FDF Dossiers, 85 FDA Orange Book, 99 Europe, 4 Canada, 8 Australia, 31 South Africa, 69 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 20MG/0.5ML (40MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 80MG/2ML (40MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 160MG/8ML (20MG/ML), INJECTABLE;INJECTION - 20MG/ML (20MG/ML), INJECTABLE;INJECTION - 80MG/4ML (20MG/ML), INJECTABLE;INJECTION - 20MG/VIAL, INJECTABLE;INJECTION - 80MG/VIAL

RELATED EXCIPIENT COMPANIES

1 Boai NKY Pharmaceuticals Ltd, 3 Nanjing Well Pharmaceutical, 2 Actylis, 2 BASF, 1 Clariant, 1 Finar, 3 Gangwal Chemicals, 1 Nanjing Bold Chemical, 6 Seppic, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

13 Solubilizers, 7 Parenteral, 7 Topical, 4 Film Formers & Plasticizers, 4 Emulsifying Agents, 4 Thickeners and Stabilizers, 3 Surfactant & Foaming Agents, 2 Rheology Modifiers, 1 Co-Processed Excipients, 1 Direct Compression, 1 Coating Systems & Additives, 1 API Stability Enhancers